This publication is provided for historical reference only and the information may be out of date.
Investigators: Karen A Robinson, MSc, Nathan Congdon, MD, MPH, Harry A Quigley, MD, Hanna Levkovitch-Verbin, MD, John Kempen, MD, MPH, and Eric B Bass, MD, MPH.
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.1 Contract No. 290-97-0006. Prepared by: Johns Hopkins University Evidence-based Practice Center, Baltimore, MD.
Jampel H, Lubomski L, Friedman D. Treatment of Coexisting Cataract and Glaucoma. Evidence Report/Technology Assessment Number 38. (Prepared by Johns Hopkins University Evidence-based Practice Center under Contract No. 290-97-0006.) AHRQ Publication No. 03-E041. Rockville, MD: Agency for Healthcare Research and Quality. June 2003.
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers—patients and clinicians, health system leaders, and policymakers—make more informed decisions and improve the quality of health care services.
The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical service.